DOI: https://dx.doi.org/10.18203/2349-3933.ijam20214880
Published: 2021-12-23

Idiopathic intracranial hypertension leading to bilateral optic atrophy in a patient with recent COVID-19 infection: a case report

Anu Yarky, Vipan Kumar, Nidhi Chauhan, Priyesh Sharma

Abstract


Neurologic complications are common in patients hospitalised with COVID-19 infection. Most common complications are myalgias, headaches, encephalopathy and dizziness. Uncommon complications are stroke, motor and sensory deficits, seizures, ataxia and movement disorders. Multiple neuro-ophthalmological manifestations have also been reported in association with COVID-19. These complications may be the result of a range of pathophysiological mechanisms like hypoxic neuronal injury during active COVID-19 infection, RAS dysfunction, immune dysfunction and direct injury by the virus etc throughout the course of the disease. Here we reported a case of neuro-ophthalmic complication of Idiopathic intracranial hypertension (IIH) followed by bilateral optic atrophy in a middle-aged man with recent COVID-19 infection. He presented to the emergency with complaints of headache, dizziness and sudden painless bilateral diminution of vision for 3 days. His fundus examination was suggestive of bilateral papilledema, his MRI brain was normal and opening pressure of CSF was raised on lumbar puncture. His MRV was normal, there was no evidence of CSVT. He was started on steroids and acetazolamide. His headache improved but there was no improvement in visual acuity. Repeat fundus showed pale disc and MRI orbit was suggestive of bilateral optic atrophy.


Keywords


Idiopathic intracranial hypertension, Optic atrophy, Papilledema

Full Text:

PDF

References


Cascella M, Rajnik M, Aleem A, Dulebohn SC, Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls; 2021.

Luís ME, Fernandes D, Mota C, Maleita D, Xavier C, Maio T, et al. A Review of Neuro-Ophthalmological Manifestations of Human Coronavirus Infection. Eye Brain. 2020;12:129-37.

Zhou S, Lopez EC, Soneji DJ, Azevedo CJ, Patel VR. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19. J Neuroophthalmol. 2020;40(3):398-402.

Hu K, Patel J, Swiston C, Patel BC. Ophthalmic Manifestations Of Coronavirus (COVID-19). StatPearls; 2021.

Montalvan V, Lee J, Bueso T, Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020;194:105921.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-4.

Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J Ophthalmol. 2021;69(3):488-509.

Brun BN, Aylward SC. Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases. Semin Pediatr Neurol. 2021;40:100922.

Sardar S, Safan A, Okar L, Sadik N, Adeli G. The diagnostic dilemma of bilateral optic neuritis and idiopathic intracranial hypertension coexistence in a patient with recent COVID-19 infection. Clin Case Rep. 2021;9(6):4347.

Elnahry AG, Elnahry GA. Management of Idiopathic Intracranial Hypertension During the COVID-19 Pandemic. Rev Recent Clin Trials. 2021;16(2):122-5.